169 related articles for article (PubMed ID: 33981594)
41. Management of male breast cancer in the United States: a surveillance, epidemiology and end results analysis.
Fields EC; DeWitt P; Fisher CM; Rabinovitch R
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):747-52. PubMed ID: 24138917
[TBL] [Abstract][Full Text] [Related]
42. Association between prolonged metastatic free interval and recurrent metastatic breast cancer survival: findings from the SEER database.
Chang E; Mougalian SS; Adelson KB; Young MR; Yu JB
Breast Cancer Res Treat; 2019 Jan; 173(1):209-216. PubMed ID: 30242577
[TBL] [Abstract][Full Text] [Related]
43. A Competing Risk Analysis Study of Prognosis in Patients with Esophageal Carcinoma 2006-2015 Using Data from the Surveillance, Epidemiology, and End Results (SEER) Database.
Yu Z; Yang J; Gao L; Huang Q; Zi H; Li X
Med Sci Monit; 2020 Jan; 26():e918686. PubMed ID: 31966000
[TBL] [Abstract][Full Text] [Related]
44. Young Patients with Hormone Receptor-Positive Breast Cancer Have a Higher Long-Term Risk of Breast Cancer Specific Death.
Fu J; Zhong C; Wu L; Li D; Xu T; Jiang T; Yang J; Du J
J Breast Cancer; 2019 Mar; 22(1):96-108. PubMed ID: 30941237
[TBL] [Abstract][Full Text] [Related]
45. Risk of cardiac-related death in astrocytoma patients treated with chemotherapy: A competing risk analysis using the SEER database.
Wang X; Li X; Wu Y; Hong J; Chai D; Zhang M
Front Cardiovasc Med; 2023; 10():996354. PubMed ID: 37180801
[TBL] [Abstract][Full Text] [Related]
46. The Survival Outcomes of T1aN0M0 Triple-Negative Breast Cancer With Adjuvant Chemotherapy.
Fu WF; Chen QX; Wang XX; Zhang J; Song CG
Front Oncol; 2020; 10():1753. PubMed ID: 33102205
[No Abstract] [Full Text] [Related]
47. Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis.
Wang D; Liu C; Zhou Y; Yan T; Li C; Yang Q; Xu Y; Zhao L; Pei Q; Tan F; Güngör C; Li Y
Radiat Oncol; 2020 May; 15(1):107. PubMed ID: 32404114
[TBL] [Abstract][Full Text] [Related]
48. Nomogram for predicting cancer specific survival in inflammatory breast carcinoma: a SEER population-based study.
Zhang H; Ma G; Du S; Sun J; Zhang Q; Yuan B; Luo X
PeerJ; 2019; 7():e7659. PubMed ID: 31576238
[TBL] [Abstract][Full Text] [Related]
49. Prognostic factors and nomogram for cancer-specific death in non small cell lung cancer with malignant pericardial effusion.
Hu ZG; Hu K; Li WX; Zeng FJ
PLoS One; 2019; 14(5):e0217007. PubMed ID: 31095610
[TBL] [Abstract][Full Text] [Related]
50. Stage IA Patients With Pancreatic Ductal Adenocarcinoma Cannot Benefit From Chemotherapy: A Propensity Score Matching Study.
Zhang Y; Xu G; Chen M; Wei Q; Zhou T; Chen Z; Shen M; Wang P
Front Oncol; 2020; 10():1018. PubMed ID: 32766130
[No Abstract] [Full Text] [Related]
51. Nomogram to Predict Cause-Specific Mortality in Patients With Surgically Resected Stage I Non-Small-Cell Lung Cancer: A Competing Risk Analysis.
Zhou H; Zhang Y; Qiu Z; Chen G; Hong S; Chen X; Zhang Z; Huang Y; Zhang L
Clin Lung Cancer; 2018 Mar; 19(2):e195-e203. PubMed ID: 29153966
[TBL] [Abstract][Full Text] [Related]
52. Immediate Breast Reconstruction in De Novo Metastatic Breast Cancer: An Analysis of 563 Cases Based on the SEER Database.
Chen H; Zhang M; Wang M; Zhang P; Bai F; Wu K
Clin Breast Cancer; 2019 Feb; 19(1):e135-e141. PubMed ID: 30497928
[TBL] [Abstract][Full Text] [Related]
53. Populational trends and outcomes of postoperative radiotherapy for high-risk early-stage cervical cancer with lymph node metastasis: concurrent chemo-radiotherapy versus radiotherapy alone.
Matsuo K; Nusbaum DJ; Machida H; Huang Y; Khetan V; Matsuzaki S; Klar M; Grubbs BH; Roman LD; Wright JD
Am J Obstet Gynecol; 2020 May; 222(5):484.e1-484.e15. PubMed ID: 31678092
[TBL] [Abstract][Full Text] [Related]
54. Development and validation of a nomogram for predicting cancer-specific survival of surgical resected stage I-II adenosquamous carcinoma of the lung.
Li H; Wang Z; Yang F; Wang J
J Surg Oncol; 2020 May; 121(6):1027-1035. PubMed ID: 32026478
[TBL] [Abstract][Full Text] [Related]
55. Chemotherapy Significantly Improves Survival for Patients with T1c-T2N0M0 Medullary Breast Cancer: 3739 Cases From the National Cancer Data Base.
Mateo AM; Pezzi TA; Sundermeyer M; Kelley CA; Klimberg VS; Pezzi CM
Ann Surg Oncol; 2017 Apr; 24(4):1050-1056. PubMed ID: 27807728
[TBL] [Abstract][Full Text] [Related]
56. The Risk of Heart Disease-Related Death Among Anaplastic Astrocytoma Patients After Chemotherapy: A SEER Population-Based Analysis.
Lin Q; Bao JH; Xue F; Qin JJ; Chen Z; Chen ZR; Li C; Yan YX; Fu J; Shen ZL; Chen XZ
Front Oncol; 2022; 12():870843. PubMed ID: 35795052
[TBL] [Abstract][Full Text] [Related]
57. Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study.
Rakha EA; Tan PH; Varga Z; Tse GM; Shaaban AM; Climent F; van Deurzen CH; Purnell D; Dodwell D; Chan T; Ellis IO
Br J Cancer; 2015 Jan; 112(2):283-9. PubMed ID: 25422911
[TBL] [Abstract][Full Text] [Related]
58. Nomogram for predicting the survival of gastric adenocarcinoma patients who receive surgery and chemotherapy.
Wang CY; Yang J; Zi H; Zheng ZL; Li BH; Wang Y; Ge Z; Jian GX; Lyu J; Li XD; Ren XQ
BMC Cancer; 2020 Jan; 20(1):10. PubMed ID: 31906882
[TBL] [Abstract][Full Text] [Related]
59. Competing-Risks Model for Predicting the Postoperative Prognosis of Patients with Papillary Thyroid Adenocarcinoma Based on The Surveillance, Epidemiology, and End Results (SEER) Database.
Bian F; Li C; Han D; Xu F; Lyu J
Med Sci Monit; 2020 Jul; 26():e924045. PubMed ID: 32710734
[TBL] [Abstract][Full Text] [Related]
60. A competing risk nomogram predicting cause-specific mortality in patients with lung adenosquamous carcinoma.
Wu X; Yu W; Petersen RH; Sheng H; Wang Y; Lv W; Hu J
BMC Cancer; 2020 May; 20(1):429. PubMed ID: 32416716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
